Effect of desipramine on patients with breathing disorders in RETT syndrome

OBJECTIVE: Rett Syndrome (RTT) is a severe neurodevelopmental condition with breathing disorders, affecting around one in 10,000 female births. Desipramine, a noradrenaline reuptake inhibitor, reduced the number of apneas in Mecp2‐deficient mice, a model of RTT. We planned a phase 2 trial to test it...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Clin Transl Neurol
Prif Awduron: Mancini, Josette, Dubus, Jean‐Christophe, Jouve, Elisabeth, Roux, Jean‐Christophe, Franco, Patricia, Lagrue, Emmanuelle, Castelnau, Pierre, Cances, Claude, Chaix, Yves, Rougeot‐Jung, Christelle, Cornu, Catherine, Desportes, Vincent, Vallée, Louis, Bahi‐Buisson, Nadia, Truillet, Romain, Attolini, Laurence, Villard, Laurent, Blin, Olivier, Micallef, Joëlle
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2017
Pynciau:
Research Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5817841/
https://ncbi.nlm.nih.gov/pubmed/29468173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.468
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg